Production calendars and shelf life: the constraint that decides your start date

The short answer: living tissue does not exist until it is made, and it is made to a calendar. There is no warehouse. When a supplier quotes a delivery date, that date is a production slot plus transit, and the slot is the scarce thing. This is the single most misunderstood fact about buying engineered tissue, and it explains the behaviour that looks like poor service but is not.

The second thing: ordering earlier in the week does not make tissue arrive sooner. One supplier ships every Monday. Ordering on Tuesday and ordering on Friday produce the same Monday dispatch. Urgency does not compress a growth cycle.

The third thing, and the one that ruins studies: the usable window on arrival is measured in days, while the QC that releases the lot finishes after it has shipped. For one published example the tissue arrives Tuesday morning, is recommended for use Tuesday afternoon, and a barrier failure is notified by Wednesday 5 p.m., with sterility failures notified within eight days of shipment.

Published schedules, side by side

Read the shipping-condition column carefully. The same manufacturer ships one product at room temperature and another at 4°C. Airway tissue travels warm; skin travels cold. Assuming a cold chain where there is none — or vice versa — leads to the wrong receiving procedure and the wrong conclusion when something looks off on arrival.

Why nothing is held in stock

Three structural reasons, and none is poor planning.

The product is alive and differentiating on a schedule. A reconstructed epithelium reaches its specified histology at a particular point in its production cycle. Held longer, it is a different tissue. There is no shelf on which it stays the product you ordered.

Production is batched into lots. MatTek states that tissue lots produced each week are assigned a lot number, with a letter appended per kit, and that all kits within a lot are identical in cells, medium, handling and culture conditions. That is a quality feature — intra-lot consistency — and it is also why supply is lumpy. A lot is grown, allocated, and gone.

Demand is allocated, not fulfilled. InSphero states that availability on a desired shipment date must be verified with a representative, and that the supplier may adjust the shipment date depending on capacity in a given week. That sentence is the whole market in miniature: your slot competes with other buyers’ slots.

The consequence for planning. Treat tissue like a reserved manufacturing slot, not a purchase. The correct question is never “how fast can you ship?” but “which production week can you commit to, and what is the order-by date for it?”

The order-by date is the real deadline

InSphero publishes order-by dates with expected delivery windows and states that, unless otherwise indicated, requests received by the listed order-by date ship on the following Tuesday to US customers or Wednesday to European customers by express delivery.

Several published operational details are worth acting on directly:

• Ordering commits you to accepting delivery within the stated expected-delivery range. This is not a shipment you can defer once placed. If your laboratory will be shut, your analyst on leave or your incubator down, that is a problem to solve before the order, not after.
• Some destinations are excluded from certain weeks. Published schedules carry footnotes for shipments outside the standard pattern, and species-specific products to certain countries require separate deadline confirmation.
• Marketplace routing is supported — ordering through Science Exchange and Scientist.com as well as direct — which matters because institutional procurement routing can add days that are invisible on the supplier’s calendar and entirely visible on yours.

The trap. Institutional purchasing adds latency between your decision and the supplier receiving the order. A purchase requisition that takes four days to clear turns a comfortable order-by date into a missed week. Count backwards from the order-by date through your own internal process, and start there.

Shelf life is short, culture window is long — do not confuse them

This distinction causes real errors, because two very different numbers are both sometimes called “how long it lasts”.

Shelf life is the period the tissue tolerates the shipping condition before being put into proper culture. MatTek states up to 3 days at room temperature including transit for EpiAirway, and up to 4 days at 4°C including transit for EpiDerm. Both explicitly include transit, so a courier delay eats your usable window directly.

Culture window is how long the tissue survives once you are maintaining it properly. For EpiAirway, MatTek states three months or more with feeding every other day. Epithelix states MucilAir remains in a stable homeostatic state for several months, even up to a year. InSphero states up to four weeks for liver microtissues.

So the correct mental model is: a narrow window to receive and stabilise, followed by a potentially long window to work. The pressure is concentrated entirely in the first 48 hours after delivery. Once the tissue is in maintenance medium in your incubator, for several of these products the urgency largely disappears.

MatTek adds a reproducibility point worth respecting: best reproducibility is obtained if tissues are used consistently on the same day — for example Tuesday afternoon, or Wednesday morning after overnight storage. If your protocol drifts across weekdays between runs, you have introduced a variable the supplier explicitly warns about.

The post-shipment QC gap

This is the operational fact that separates experienced buyers from everyone else, and MatTek is unusually honest in publishing it.

Because QC and sterility testing are performed post-shipment, notification is made as soon as possible: TEER failures notified by Wednesday 5 p.m., sterility failures within eight days of shipment. If a lot fails, the customer is notified and tissues are replaced without charge where appropriate.

Lay that against the delivery schedule:

Day	Event
Monday	Tissue ships
Tuesday morning	Tissue arrives
Tuesday afternoon	Recommended use day — experiment starts
Wednesday 5 p.m.	Earliest notification of a barrier failure
Up to 8 days after shipment	Earliest notification of a sterility failure

You can be a week into a three-month chronic study before you learn the lot was not sterile. The replacement policy covers the cost of the tissue. It does not cover your compound, your analyst’s time, the instrument booking, or the study timeline.

What to do about it:

1. Measure the barrier yourself on arrival. For airway tissue MatTek publishes its own release floor — a minimum TEER of 300 Ω·cm² on an EVOM2 with an Endohm chamber — so you have a number to compare against without waiting.
2. Delay dosing past the QC window on long studies where the culture window permits it. For a three-month airway study, waiting two days costs nothing and removes the largest risk.
3. Split long or expensive studies across two lots, so one failure does not take everything.
4. Record the lot number and kit letter against every plate. It is the only way a claim gets traced, and MatTek’s lot-letter scheme exists precisely for this.
5. Ask actively for the sterility result at the eight-day mark. Silence is not a pass.

Arrival QC: what to check in the first hour

Regardless of supplier, the receiving procedure is the same shape, and it must happen on the day.

Inspect and photograph before moving anything. Condition of the packaging, the agarose gel, any temperature indicator, the plate seals. Photographs taken before handling are the only evidence that survives a dispute.

Read the temperature record if one is supplied. Some products ship with a disposable USB temperature recorder that writes a PDF directly to the drive; the supplier asks for it back. Do it on the day, not at the end of the study.

Count what arrived. InSphero states that all plates shipped had microtissues in every well destined to be filled, confirmed by optical scans of each plate, and guarantees at least 95 percent of microtissues will be available for use on arrival. Where a numerical guarantee exists, counting is the acceptance test, and both sides have evidence.

Measure the barrier, where the tissue is a barrier model, before anything is dosed.

Change to the correct medium immediately. Where a product ships with more than one medium, using the wrong one at the first change is a protocol error rather than a preference — the distinction between a dosing medium and a maintenance medium is real and is documented per product.

Keep the certificate of analysis and the lot information with the experiment record.

Planning backwards: a worked sequence

For a study that must start on a given Monday, with a weekly-cadence supplier:

1. Target start date — the Monday you need data collection to begin.
2. Subtract stabilisation. One to two days between delivery and first use, so the tissue arrives the preceding week.
3. Subtract the QC gap, if the study is long or expensive — two more days to clear the barrier notification window.
4. Land on a delivery date, then map it to the supplier’s dispatch day: Monday dispatch means Tuesday delivery domestically, Tuesday–Thursday internationally.
5. Find the order-by date for that production week, from the published schedule, confirmed with a named representative rather than assumed.
6. Subtract your own procurement latency — requisition approval, PO issue, marketplace routing. This is frequently the largest single block and the one nobody counts.
7. Subtract the media-variant lead time, if you need one. Phenol-red-free, antibiotic-free or anti-fungal-free tissue requires the agent removed at least three days before shipment, so the variant must be specified upstream and cannot be arranged after the lot is grown.
8. Add contingency for one missed week. Capacity adjustments happen and are disclosed as possible by suppliers themselves.

Run that arithmetic and a “two-week lead time” routinely becomes four to five weeks from decision to data. That is not a supplier failing. It is what the calendar actually is, and planning against the real number is the whole point.

Where the calendar does not apply

Two categories escape these mechanics, and it is worth knowing which purchase you are making.

Devices and empty consumables. Casting plates, chips and inserts are manufactured goods with ordinary consumable lead times. They ship fast; the biology you then have to grow is what takes the time.

Cryopreserved cells. A vial in a freezer is inventory in the normal sense. Availability is a stock question, not a production-slot question, and the long pole moves to your own expansion and differentiation time.

The general lead-time picture across categories, including custom programmes, is in realistic lead times for cells, tissue and custom devices.

Checklist before committing to a tissue delivery date

• The production week, named, and its order-by date, confirmed with a person.
• Your own procurement latency, counted backwards from that order-by date.
• Dispatch day and expected delivery window to your actual address, not to your country.
• Whether your destination is restricted in that week.
• Shipping condition — ambient or refrigerated — and the receiving procedure that matches it.
• Shelf life on arrival, and whether it includes transit. It usually does.
• Culture window after stabilisation, against your study length.
• Media variants, ordered upstream with the removal window respected.
• Post-shipment QC timing for barrier and for sterility, stated in writing.
• Kit size and minimum order, against your replicate count.
• Who signs for it, and whether they will be there. Delivery cannot be deferred once ordered.
• A named contact at the supplier for the week of dispatch.

Where to go next

• Engineered tissue map — the three availability clusters and how each behaves.
• Airway and respiratory models — the longest published culture windows in the category, and the published QC notification policy.
• Liver microtissues and spheroids — the clearest published order-by-date regime, with an availability guarantee on arrival.
• Shipping live cells and tissue — formats, risks and inspection procedure.
• Realistic lead times — across cells, tissue, devices and custom programmes.

How we can help

The failure we see most is a calendar collision: a study start date that never lined up with a production week, discovered when the order-by date had already passed. The second is a delivery that lands correctly and sits in a corridor because nobody was told to expect it.

We check published production schedules against your target start date before anything is committed, count your institution’s own procurement latency into the backward plan, confirm media variants are specified upstream of the removal window, get the post-shipment QC notification timing stated in writing so your dosing schedule does not sit inside the gap, and make sure a named person is expecting the box on the day it lands.

Tell us the date data collection has to start, and where the tissue is going.